Micro-X (ASX:MX1) is a publicly listed company dedicated to becoming global leaders in imaging

Our world-leading Nano Electronic X-ray (NEX) Technology forms the core of a common platform for all our products, delivering quality digital imaging through proprietary high-voltage X-ray tubes and high-voltage generators.

Micro-X develops and commercializes innovative products for global health and security markets. We create revolutionary X-ray imaging to better lives.

With a vertically integrated design and production facility in Adelaide, Australia and a strong technical and commercial team based in Seattle, USA, we are focused on delivering exceptional innovative products to underpin our commercial growth.

About us

Recent announcements

See all
Annual Report
Investor Presentations
Corporate Governance
X Symbol

Our 2024 Annual Report is now available

Find our how our year went.

Download our 2024 Annual Report
A close up of our xray Machine

Analyst coverage

Please contact research analysts listed below to receive their latest research on Micro-X.

Scott Power, Morgans Financial

1800 777 946

scott.power@morgans.com.au

Shareholder information

Micro-X is listed on the Australian Securities Exchange (ASX), trading as MX1. Computershare maintains our ASX shareholder registry. For all enquiries relating to your shareholding, contact:

The Registrar
Computershare Investor Services Pty Ltd
GPO Box 2975
Australia

Aus: 1300 555 159
Intl: +61 (0)3 9415 4062

Shareholders can access information on their holding online with Computershare.

Purchasing MX1 stock outside Australia

Overseas investors can purchase ASX-listed shares, including Micro-X, through a number of local brokers. Please enquire with your broker if they enable you to trade ASX shares, or contact us to help identify a broker at:

admin@micro-x.com

Latest News & Media

All News
Micro-X Rover Set to Make College Basketball Debut
arrow up right
April 3, 2025

Discover how the Micro-X Rover, a revolutionary portable X-ray system, is making its debut at the NCAA Final Four in San Antonio. Learn how it’s transforming sports medicine by delivering hospital-quality imaging directly to athletes.

2025 Newsletter 1
arrow up right
April 2, 2025

From expanding the reach of our lightweight mobile X-ray solutions to progressing our game-changing CT imaging technology, 2025 will be about commercial success and delivering benefits to patients and clinicians globally.

Presentation to 2025 ASMIRT Conference
arrow up right
April 1, 2025

See the presentation given by Chief Operating Officer Anthony Skeats to medical radiation professionals from across Australia and New Zealand on the development of miniaturised CT for stroke detection that can be retrofitted into a standard air or road ambulance.